Literature DB >> 19671223

Prognostic significance of periodic acid-Schiff-positive patterns in clear cell renal cell carcinoma.

Amalia A Vartanian1, Eugenia V Stepanova, Sergey L Gutorov, Elico Sh Solomko, Irina N Grigorieva, Irina N Sokolova, Anatoly Yu Baryshnikov, Mikhail R Lichinitser.   

Abstract

BACKGROUND: The ability of aggressive tumors to form nonendothelial tumor cell-lined microvascular channels is known as "vasculogenic mimicry" (VM). VM channels are revealed as periodic acid-Schiff (PAS)-positive patterns, and in some tumors their presence predicts clinical outcomes.
OBJECTIVE: We aimed to study VM channels in clear cell renal cell carcinoma (cRCC) tumors and explore their prognostic significance and relationship to other suggested prognostic factors such as thymidine phosphorylase (TP) and vascular endothelial growth factor (VEGF) expression.
METHODS: We retrospectively studied 45 patients who had undergone radical nephrectomy for clinically confined cRCC (stage T2-T3NOMO) at the Russian Cancer Research Center. The tumor sections were reviewed for disease stage, nuclear grade, perirenal fat invasion, and lymph node involvement, and we performed immunohistochemical staining for VEGF and TP expression, and PAS staining. Disease-free survival probabilities were determined by Kaplan-Meier estimates and prognostic factors were evaluated by univariate analysis.
RESULTS: PAS-positive patterns observed in the cRCC tumor included back-to-back closed loops, networks, arcs, and parallel patterns. There was a significant decrease in disease-free survival among patients with PAS-positive networks (p = 0.005), but not among patients with other PAS-positive patterns. TP expression was also a significant predictor of disease-free survival (p = 0.035), but this factor did not correlate with the presence of PAS-positive networks. Notably, in our small sample, the six patients whose tumors were positive for both factors had the highest risk of cancer recurrence.
CONCLUSIONS: The presence of PAS-positive networks is an independent and relevant prognostic parameter for disease-free survival in patients with cRCC. Our data suggest that the combination of PAS-positive networks and TP expression may identify patients with the highest risk of cancer recurrence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19671223

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  23 in total

1.  Transforming growth factor-β is required for vasculogenic mimicry formation in glioma cell line U251MG.

Authors:  Gengqiang Ling; Shiyong Wang; Zhenhua Song; Xinlin Sun; Yijing Liu; Xiaodan Jiang; Yingqian Cai; Mouxuan Du; Yiquan Ke
Journal:  Cancer Biol Ther       Date:  2011-12-01       Impact factor: 4.742

Review 2.  Autophagy, a double-edged sword in anti-angiogenesis therapy.

Authors:  Jiatao Liu; Lulu Fan; Hua Wang; Guoping Sun
Journal:  Med Oncol       Date:  2015-12-29       Impact factor: 3.064

3.  Vasculogenic mimicry is a prognostic factor for postoperative survival in patients with glioblastoma.

Authors:  Shi-Yong Wang; Yi-Quan Ke; Guo-Hui Lu; Zhen-Hua Song; Li Yu; Sha Xiao; Xin-Lin Sun; Xiao-Dan Jiang; Zhi-Lin Yang; Chang-Chen Hu
Journal:  J Neurooncol       Date:  2013-02-16       Impact factor: 4.130

Review 4.  The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma.

Authors:  Sunao Shoji; Mayura Nakano; Haruhiro Sato; Xian Yang Tang; Yoshiyuki Robert Osamura; Toshiro Terachi; Toyoaki Uchida; Koichi Takeya
Journal:  Clin Exp Metastasis       Date:  2014-01       Impact factor: 5.150

5.  Expression of maspin in non-small cell lung cancer and its relationship to vasculogenic mimicry.

Authors:  Shiwu Wu; Lan Yu; Zenong Cheng; Wenqing Song; Lei Zhou; Yisheng Tao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-06-09

6.  Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy.

Authors:  Yue-Zu Fan; Wei Sun
Journal:  World J Gastrointest Surg       Date:  2010-04-27

7.  Combretastatin A4 phosphate treatment induces vasculogenic mimicry formation of W256 breast carcinoma tumor in vitro and in vivo.

Authors:  Nan Yao; Ke Ren; Cuihua Jiang; Meng Gao; Dejian Huang; Xiao Lu; Bin Lou; Fei Peng; Aizhen Yang; Xiaoning Wang; Yicheng Ni; Jian Zhang
Journal:  Tumour Biol       Date:  2015-05-31

8.  HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.

Authors:  Na-Na Tang; Hong Zhu; Hong-Jie Zhang; Wei-Feng Zhang; Hai-Lin Jin; Lu Wang; Pin Wang; Gui-Jun He; Bo Hao; Rui-Hua Shi
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

9.  Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma.

Authors:  Wen-bin Liu; Ge-liang Xu; Wei-dong Jia; Jian-sheng Li; Jin-liang Ma; Ke Chen; Zhi-hua Wang; Yong-sheng Ge; Wei-hua Ren; Ji-hai Yu; Wei Wang; Xiu-Jun Wang
Journal:  Med Oncol       Date:  2010-10-19       Impact factor: 3.064

10.  Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanoma.

Authors:  Orit Itzhaki; Eyal Greenberg; Bruria Shalmon; Adva Kubi; Avraham J Treves; Ronnie Shapira-Frommer; Camilla Avivi; Rona Ortenberg; Eytan Ben-Ami; Jacob Schachter; Michal J Besser; Gal Markel
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.